InvestorsHub Logo
Followers 8
Posts 450
Boards Moderated 0
Alias Born 10/04/2010

Re: None

Sunday, 03/19/2017 1:57:23 PM

Sunday, March 19, 2017 1:57:23 PM

Post# of 3833
Those of you dreaming about a partnership with a major pharma regarding psoriasis or atopic dermatitis need to look at slide 69 of the latest NVS corporation presentation: https://www.novartis.com/sites/www.novartis.com/files/q4-2016-ir-presentation-development.pdf

NVS obviously looked at GALT before making the partnership agreement with CNAT and passed, I don't see how GALT can get anywhere with their very limited atopic dermatitis data when NVS is so far along in the development cycle (Phase 2 already complete).

I won't repeat what I've already said about GALT's future being completely reliant on the CX trial but that's it, period.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News